Mechanistic Rationale NNMT consumes nicotinamide and SAM to produce 1-MNA and S-adenosylhomocysteine (SAH)
This pattern is consistent with what researchers would expect for a compound where placebo effects, injury variability, and administration differences all contribute noise to self-reported outcomes
High-Purity Medical-Grade Research Compound 99% Purity Verified for Laboratory & Scientific Research
The method of embodiment 113, wherein the copolymer of polyoxyethylene and polyoxypropylene is poloxamer 407
Ready to Explore Further
Drug interactions Curcumin has been found to inhibit platelet aggregation in vitro (113, 114), suggesting a potential for curcumin supplementation to increase the risk of bleeding in people taking anticoagulant or antiplatelet medications, such as aspirin, clopidogrel (Plavix), dalteparin (Fragmin), enoxaparin (Lovenox), heparin, ticlopidine (Ticlid), and warfarin (Coumadin)